MaxWell Biosystems is a Swiss technology provider, leader in high-content electrophysiology platforms advancing scientific discovery and accelerating drug discovery for neurodegenerative diseases.
We are delighted to count MaxWell Biosystems among our partners. Together, we are fostering electrophysiological research on Human iPSC-derived neurons and other neuronal cultures, from neuronal networks to single neuron resolution.
Thanks to our common work will enable the pharmaceutical industry to access state-of-the-art technology and expertise and assess their compounds’ efficacy on human tissue.
Read the full partnership announcement here